Dr. Pongpak Pongphitcha

About Dr. Pongpak Pongphitcha

Dr. Pongpak Pongphitcha is a pediatric hematologist-oncologist at Bangkok Hospital.
He is affiliated with the Child’s Health Centre at Bangkok Hospital.
He is a member of the Thai Medical Council.
He completed his Doctor of Medicine (First Class Honours) at Ramathibodi Hospital, Mahidol University, Thailand 2012.
He obtained his Paediatrics Residency from Ramathibodi Hospital, Mahidol University, Thailand in 2016.
Fluent in Thai & English.

Conditions treated by Dr. Pongpak Pongphitcha

Thalassemia
Hemophilia
Anaemia (iron deficiency, aplastic anaemia, etc.)
Sickle cell disease
Platelet disorders
White blood cell disorders
Leukaemia (ALL, AML)
Lymphomas (Hodgkin’s and non-Hodgkin’s)
Neuroblastoma
Wilms' tumour (kidney cancer)
Brain tumors
Bone cancer

Area of Interest

Pediatric Hematology
Pediatric Oncology
Stem Cell Transplantation

Qualification

Doctor of Medicine (First Class Honours), Ramathibodi Hospital, Mahidol University, Thailand (2012).

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Pongpak Pongphitcha on our platform

Consult Online

CERTIFICATIONS (3)

Board Certification in Paediatrics, Thai Medical Council, Thailand 2016.
Fellowship in Pediatric Haematology and Oncology, Ramathibodi Hospital, Mahidol University, Thailand, 2018.
Certification in Pediatric Haematology and Oncology, Thai Medical Council, Thailand, 2018.

MEMBERSHIPS (1)

The Thai Medical Council

RESEARCH PAPERS AND PUBLICATIONS (3)

Co-authored the study titled "Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen", published in Biology of Blood and Marrow Transplantation, 2020.
Co-authored the study "HApplication of Gene Expression Microarray for the Classification of Ph‐Like B‐Cell Acute Lymphoblastic Leukaemia", published in the International Journal of Laboratory Haematology, 2024.
Co-authored the "Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma" study published in the journal, Cancers, 2022.

Share Your Experience about Dr. Pongpak Pongphitcha

Write Your Review

PROCEDURES

Castleman Disease Treatment

FREQUENTLY ASKED QUESTIONS

Q: Is Dr. Pongpak Pongphitcha’s teleconsultation on the MediGence platform?

A. Dr. Pongpak Pongphitcha is available to teleconsult on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

Q: How soon can the consultation be organised?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is a follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Can we get an estimate for the procedure?

A. Yes. Our case manager will provide the cost estimate, including the doctor’s opinion, the cost estimate, and the crucial information about travelling to your medical destination.

Welcome To MediGence

Your Notifications